Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SNCA | P37840 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | CHRNA1 | P02708 | 2/20 | 0.33 |
| ▸ | CHRNG | P07510 | 2/20 | 0.33 |
| ▸ | CHRNB1 | P11230 | 2/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.33 |
| ▸ | CHRND | Q07001 | 2/20 | 0.33 |
| ▸ | LPL | P06858 | 3/20 | 0.32 |
| ▸ | LIPG | Q9Y5X9 | 3/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4266060 | 0.94 | SNCA (0.43) | SNCALPLLIPGPTGS1PTGS2 | |
| SCHEMBL4264297 | 0.89 | SNCA (0.44) | SNCALPLLIPG | |
| SCHEMBL4257326 | 0.83 | SNCA (0.48) | SNCALPLLIPG | |
| SCHEMBL12370809 | 0.82 | SNCA (0.41) | SNCACHRNA1CHRNGCHRNB1CHRNB2 | |
| SCHEMBL5892468 | 0.80 | SNCA (0.35) | SNCACHRNA1CHRNGCHRNB1CHRNB2 | |
| SCHEMBL3186952 | 0.80 | SNCA (0.40) | SNCALPLLIPGKMT2A | |
| SCHEMBL3711441 | 0.80 | SNCA (0.40) | SNCALPLLIPG | |
| SCHEMBL5528199 | 0.80 | SNCA (0.40) | SNCALPLLIPGCYP2A6 | |
| SCHEMBL1136930 | 0.80 | LPL (0.52) | SNCACHRNA1CHRNGCHRNB1CHRNB2 | |
| SCHEMBL9935185 | 0.80 | SNCA (0.40) | SNCALPLLIPGLMNAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9802963-B2 | Fluorine-containing complex compound, and production method for fluorine-containing organic compound employing same | DAIKIN INDUSTRIES, LTD. (JP) | 2017-10-31 | — | — | US | disclosed |
| US-20160214999-A1 | FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME | DAIKIN INDUSTRIES, LTD. (JP) | 2016-07-28 | — | — | US | disclosed |
| US-20070105826-A1 | Novel fusidic acid derivatives | LEO PHARMA A/S (DK) | 2007-05-10 | — | — | US | disclosed |
| EP-1658305-A1 | NOVEL FUSIDIC ACID DERIVATIVES | Leo Pharma A/S (DK) | 2006-05-24 | — | — | EP | disclosed |
| WO-2005007669-A1 | NOVEL FUSIDIC ACID DERIVATIVES | LEO PHARMA A/S (DK) | 2005-01-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160214999-A1 | FLUORINE-CONTAINING COMPLEX COMPOUND, AND PRODUCTION METHOD FOR FLUORINE-CONTAINING ORGANIC COMPOUND EMPLOYING SAME | AFF1, AFF2, AFF4 | SNCA 1133/4885MAPK1 1414/4885CHRNA1 2761/4885 |
| US-20070105826-A1 | Novel fusidic acid derivatives | FUS, Q6ZSR9, RPL24 | SNCA 4592/4885MAPK1 2474/4885CHRNA1 4880/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.